Coagulopathy with midtrimester induced abortion: association with hyperosmolar urea administration

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Maternal-Fetal Medicine

Background:

• Midtrimester abortion induction commonly utilizes intra-amniotic agents.
• Previous reports suggest subclinical coagulation changes with various agents.
• Clinically significant coagulopathy is a known risk with hypertonic sodium chloride.

Observation:

• This study reviewed 3,034 cases of midtrimester elective abortion over three years.
• Coagulopathy was observed in six cases following hypertonic sodium chloride administration.
• Two cases of coagulopathy were noted after hyperosmolar urea administration.

Findings:

• Hypertonic sodium chloride and hyperosmolar urea are associated with coagulopathy during midtrimester abortion.
• The incidence of clinically significant coagulopathy, though rare, warrants attention.
• Understanding the etiology of these coagulation changes is crucial for patient safety.

Implications:

• These findings highlight the importance of monitoring coagulation status in patients undergoing midtrimester abortion.
• Further research into the mechanisms underlying drug-induced coagulopathy is recommended.
• Clinical protocols may need to be reviewed to mitigate risks associated with specific abortifacients.